EMERGENT BIOSOLUTIONS INC. Capital Expenditures Incurred but Not yet Paid
EMERGENT BIOSOLUTIONS INC. (EBS) reported Capital Expenditures Incurred but Not yet Paid of $2.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $1.60M, a 128.57% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.00M, a 33.33% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$200.00K, a 166.67% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$400.00K.
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for fiscal 2025 was $1.60M, a 15.79% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for fiscal 2024 was $1.90M, a 66.67% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for fiscal 2023 was $5.70M, a 39.36% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. capital expenditures incurred but not yet paid for fiscal 2022 was $9.40M, a 53.00% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.60M 10-Q · filed 2026-08-06 | $2.40M derived: sum of 3 quarters · filed 2026-08-06 | $2.00M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $1.00M 10-Q · filed 2026-05-01 | $800.00K derived: sum of 2 quarters · filed 2026-05-01 | $400.00K derived: sum of 3 quarters · filed 2026-05-01 | $1.10M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$600.00K derived: sum of 2 quarters · filed 2026-02-27 | $100.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.60M 10-K · filed 2026-02-27 | |
| 2025-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $300.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.80M 10-Q · filed 2025-10-30 | $2.10M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.20M 10-Q · filed 2026-08-06 | $2.50M derived: sum of 3 quarters · filed 2026-08-06 | $1.20M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.50M 10-Q · filed 2026-05-01 | $1.80M derived: sum of 2 quarters · filed 2026-05-01 | $500.00K derived: sum of 3 quarters · filed 2026-05-01 | $100.00K derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.00M derived: sum of 2 quarters · filed 2026-02-27 | -$1.40M derived: sum of 3 quarters · filed 2026-02-27 | $1.90M 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$1.70M derived: sum of 2 quarters · filed 2025-10-30 | $1.60M 10-Q · filed 2025-10-30 | -$1.90M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.90M 10-Q · filed 2025-08-07 | -$600.00K derived: sum of 3 quarters · filed 2026-02-27 | $900.00K derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $3.30M 10-Q · filed 2025-05-08 | -$200.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.30M derived: sum of 3 quarters · filed 2026-02-27 | $1.20M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | -$3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.00M derived: sum of 2 quarters · filed 2026-02-27 | -$2.10M derived: sum of 3 quarters · filed 2026-02-27 | $5.70M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.40M derived: sum of 2 quarters · filed 2024-11-07 | $9.20M 10-Q · filed 2024-11-07 | $8.60M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $7.70M 10-Q · filed 2024-08-07 | $7.10M derived: sum of 3 quarters · filed 2025-03-04 | $9.80M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-03-31 | $7.80M 10-Q · filed 2024-05-02 | $7.20M derived: sum of 2 quarters · filed 2025-03-04 | $9.90M derived: sum of 3 quarters · filed 2025-03-04 | $3.90M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2022-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $2.10M derived: sum of 2 quarters · filed 2025-03-04 | -$3.90M derived: sum of 3 quarters · filed 2025-03-04 | $9.40M 10-K · filed 2025-03-04 | |
| 2022-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11 | -$3.30M derived: sum of 2 quarters · filed 2023-12-11 | $10.00M 10-Q · filed 2023-12-11 | $9.40M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-06-30 | -$6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.30M 10-Q · filed 2023-08-09 | $6.70M derived: sum of 3 quarters · filed 2024-03-08 | -$4.40M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-03-31 | $13.30M 10-Q · filed 2023-05-10 | $12.70M derived: sum of 2 quarters · filed 2024-03-08 | $1.60M derived: sum of 3 quarters · filed 2024-03-08 | $800.00K derived: sum of 4 quarters · filed 2024-03-08 | |
| 2021-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$11.70M derived: sum of 2 quarters · filed 2024-03-08 | -$12.50M derived: sum of 3 quarters · filed 2024-03-08 | $20.00M 10-K · filed 2024-03-08 | |
| 2021-09-30 | -$11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$11.90M derived: sum of 2 quarters · filed 2022-11-09 | $20.60M 10-Q · filed 2022-11-09 | $33.80M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2021-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $31.70M 10-Q · filed 2022-08-02 | $44.90M derived: sum of 3 quarters · filed 2023-12-11 | $37.80M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2021-03-31 | $32.50M 10-Q · filed 2022-04-29 | $45.70M derived: sum of 2 quarters · filed 2023-12-11 | $38.60M derived: sum of 3 quarters · filed 2023-12-11 | $48.10M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2020-12-31 | $13.20M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $6.10M derived: sum of 2 quarters · filed 2023-12-11 | $15.60M derived: sum of 3 quarters · filed 2023-12-11 | $22.90M 10-K/A · filed 2023-12-11 | $22.00M 10-K · filed 2021-02-19 |
| 2020-09-30 | -$7.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.40M derived: sum of 2 quarters · filed 2021-11-05 | $9.70M 10-Q · filed 2021-11-05 | $3.90M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $16.80M 10-Q · filed 2021-07-30 | $11.00M derived: sum of 3 quarters · filed 2022-02-25 | $17.70M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $7.30M 10-Q · filed 2021-04-30 | $1.50M derived: sum of 2 quarters · filed 2022-02-25 | $8.20M derived: sum of 3 quarters · filed 2022-02-25 | $12.50M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $900.00K derived: sum of 2 quarters · filed 2022-02-25 | $5.20M derived: sum of 3 quarters · filed 2022-02-25 | $12.30M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $11.00M derived: sum of 2 quarters · filed 2020-11-06 | $18.10M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $11.40M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $7.10M 10-Q · filed 2020-05-01 | ||||
| 2018-12-31 | $14.70M 10-K · filed 2021-02-19 | ||||
| 2017-12-31 | $4.60M 10-K · filed 2020-02-25 | $4.59M 10-K · filed 2018-02-23 | |||
| 2016-12-31 | $13.50M 10-K · filed 2019-02-22 | $13.46M 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $4.38M 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | $5.39M 10-K · filed 2017-02-28 | ||||
| 2013-12-31 | $2.75M 10-K · filed 2016-02-29 | ||||
| 2012-12-31 | $5.61M 10-K · filed 2015-03-09 | ||||
| 2011-12-31 | $13.51M 10-K · filed 2014-03-10 | $15.51M 10-K · filed 2012-03-09 | |||
| 2010-12-31 | $3.52M 10-K · filed 2013-03-08 | ||||
| 2009-12-31 | $2.75M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |